![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Subunit Is the Latch for Triggered Activation of Heterotrimeric G Proteins
Institute of Pharmacology, Center of Biomolecular Medicine and Pharmacology, Medical University of Vienna (C.N., R.K., Q.Y., E.F., M.F.); and Boehringer-Ingelheim Austria GmbH, Vienna, Austria (H.A.)
The receptor-mimetic peptide D2N, derived from the cytoplasmic domain of the D2 dopamine receptor, activates G protein
-subunits (Gi and Go) directly. Using D2N, we tested the current hypotheses on the mechanism of receptor-mediated G protein activation, which differ by the role assigned to the G
-subunit: 1) a receptor-prompted movement of G
is needed to open up the nucleotide exit pathway ("gear-shift" and "lever-arm" model) or 2) the receptor first engages G
and then triggers GDP release by interacting with the carboxyl (C) terminus of G
(the "sequential-fit" model). Our results with D2N were compatible with the latter hypothesis. D2N bound to the extreme C terminus of the
-subunit and caused a conformational change that was transmitted to the switch regions. Hence, D2N led to a decline in the intrinsic tryptophan fluorescence, increased the guanine nucleotide exchange rate, and modulated the Mg2+ control of nucleotide binding. A structural alteration in the outer portion of helix
5 (substitution of an isoleucine by proline) blunted the stimulatory action of D2N. This confirms that helix
5 links the guanine nucleotide binding pocket to the receptor contact site on the G protein. However, neither the
-subunit amino terminus (as a lever-arm) nor G
was required for D2N-mediated activation; conversely, assembly of the G

heterotrimer stabilized the GDP-bound species and required an increased D2N concentration for activation. We propose that the receptor can engage the C terminus of the
-subunit to destabilize nucleotide binding from the "back side" of the nucleotide binding pocket.
Address correspondence to: Dr. C. Nanoff, Medical University of Vienna, Institute of Pharmacology, Waehringer Stra
e 13, A-1090 Vienna, Austria. E-mail: christian.nanoff{at}meduniwien.ac.at
This article has been cited by other articles:
![]() |
J. R. Lane, B. Powney, A. Wise, S. Rees, and G. Milligan G Protein Coupling and Ligand Selectivity of the D2L and D3 Dopamine Receptors J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 319 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Knierim, K. P. Hofmann, O. P. Ernst, and W. L. Hubbell Sequence of late molecular events in the activation of rhodopsin PNAS, December 18, 2007; 104(51): 20290 - 20295. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Johnston and D. P. Siderovski Receptor-Mediated Activation of Heterotrimeric G-Proteins: Current Structural Insights Mol. Pharmacol., August 1, 2007; 72(2): 219 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Johnston and D. P. Siderovski Structural basis for nucleotide exchange on G{alpha}i subunits and receptor coupling specificity PNAS, February 6, 2007; 104(6): 2001 - 2006. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Herrmann, M. Heck, P. Henklein, K. P. Hofmann, and O. P. Ernst Signal Transfer from GPCRs to G Proteins: ROLE OF THE G{alpha} N-TERMINAL REGION IN RHODOPSIN-TRANSDUCIN COUPLING J. Biol. Chem., October 6, 2006; 281(40): 30234 - 30241. [Abstract] [Full Text] [PDF] |
||||